Koers Access Pharmaceuticals, Inc. OTC Bulletin Board
Aandelen
ACCP
US00431M3088
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
16/05 | ABEONA THERAPEUTICS INC. : Cantor Fitzgerald ontvangt een koopadvies | ZM |
15/05 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
Omzet 2024 * | - | Omzet 2025 * | 17,18 mln. 15,81 mln. | Marktkapitalisatie | 174 mln. 160 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -56 mln. -51,53 mln. | Nettowinst (verlies) 2025 * | -59 mln. -54,29 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 10,2 x |
K/w-verhouding 2024 * |
-3,24
x | K/w-verhouding 2025 * |
-2,81
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,64% |
Recentste transcriptie over Access Pharmaceuticals, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 01-06-21 |
Michael Amoroso
CHM | Chairman | 46 | 09-07-20 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 14-03-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 01-03-06 |
Faith Charles
BRD | Director/Board Member | 62 | 25-03-21 |
Leila Alland
BRD | Director/Board Member | 61 | 19-04-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,09% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-4,96% | 29,18 mld. | |
+11,18% | 26,02 mld. | |
-21,95% | 18,9 mld. | |
+8,61% | 13,21 mld. | |
+24,73% | 12,17 mld. | |
+28,31% | 12,16 mld. | |
-6,26% | 11,42 mld. |
- Beurs
- Aandelen
- Koers ABEO
- Koers ACCP